Document Detail


The current status of antihypertensive treatments: into the new millennium.
MedLine Citation:
PMID:  11336618     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this short review, we present a historical perspective of the treatment of hypertension, highlight some current issues and look to the possible future of antihypertensive therapy. The distribution of blood pressure within the population adopts a continuous, albeit somewhat skewed, distribution, so what constitutes hypertension? Conventionally, the disease has been defined as a level of blood pressure >> 140/90 mmHg. Accepting this 'arbitrary' definition infers that approximately one quarter of the adult population in the US are hypertensive [1]. This has significant implications in terms of the impact upon public health. We know that treatment of hypertension can prevent the serious consequences of cardiovascular disease: stroke, myocardial infarction (MI), heart failure and renal disease. Thus, it is important that raised blood pressure is both detected and effectively lowered. To what level should blood pressure be reduced. Conventionally, a level of 120/80 mmHg has been used to define normotension but there are indications that under certain circumstances this should not be the target. The question also arises as to whether it matters how blood pressure is treated. The choice of agent may ultimately depend upon the presence of any concomitant condition and risk factors. Recent trial evidence has concluded that therapy selected to treat raised blood pressure should take into account the overall cardiovascular risk profile of the patient [2].
Authors:
T C Hardman; M W Lunnon
Related Documents :
20687078 - Hydralazine for essential hypertension.
683938 - Methyclothiazide in hypertension. a report from the general practitioner research group.
10701818 - A clinic and community-based approach to hypertension control for an underserved minori...
9809928 - Use of radial artery applanation tonometry and a generalized transfer function to deter...
9141918 - Early hemodynamic effects of left atrial administration of epinephrine after cardiac tr...
7235038 - Abnormalities in baroreflex control of heart rate in canine heart failure.
Publication Detail:
Type:  Editorial; Review    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  2     ISSN:  1465-6566     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2001 May 
Date Detail:
Created Date:  2001-05-04     Completed Date:  2002-09-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  731-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Clinical Trials as Topic
Humans
Hypertension / drug therapy*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical review of glimepiride.
Next Document:  Cardioprotection: emerging pharmacotherapy.